At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine. In 2020, our products reached approximately 500 million patients worldwide and our aspiration is to reach one billion.1
Sandoz is a global leader in generic pharmaceuticals and biosimilars, in areas ranging from cardiovascular, central nervous system, pain and ophthalmology to oncology, respiratory and hormonal therapeutics.
Our broad portfolio is backed by a range of state-of-the-art technologies, formulations and devices, including prolonged-release and multiple-unit tablets, creams and gels, orodispersible films, transdermal patches, lyophilized products, implants and inhalers.